Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP
- 15 June 2001
- journal article
- Published by American Society of Hematology in Blood
- Vol. 97 (12) , 3867-3874
- https://doi.org/10.1182/blood.v97.12.3867
Abstract
X-linked lymphoproliferative disease (XLP) is a rare immune disorder commonly triggered by infection with Epstein-Barr virus. Major disease manifestations include fatal acute infectious mononucleosis, B-cell lymphoma, and progressive dys-gammaglobulinemia. SAP/SH2D1A, the product of the gene mutated in XLP, is a small protein that comprises a single SH2 domain and a short tail of 26 amino acids. SAP binds to a specific motif in the cytoplasmic tails of the cell surface receptors SLAM and 2B4, where it blocks recruitment of the phosphatase SHP-2. Here it is reported that Ly-9 and CD84, 2 related glycoproteins differentially expressed on hematopoietic cells, also recruit SAP. Interactions between SAP and Ly-9 or CD84 were analyzed using a novel yeast 2-hybrid system, by COS cell transfections and in lymphoid cells. Recruitment of SAP is most efficient when the specific tyrosine residues in the cytoplasmic tails of Ly-9 or CD84 are phosphorylated. It is concluded that in activated T cells, the SAP protein binds to and regulates signal transduction events initiated through the engagement of SLAM, 2B4, CD84, and Ly-9. This suggests that combinations of dysfunctional signaling pathways initiated by these 4 cell surface receptors may cause the complex phenotypes of XLP.Keywords
This publication has 18 references indexed in Scilit:
- Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4International Immunology, 2000
- Cutting Edge: Defective NK Cell Activation in X-Linked Lymphoproliferative DiseaseThe Journal of Immunology, 2000
- Cutting Edge: Functional Requirement for SAP in 2B4-Mediated Activation of Human Natural Killer Cells as Revealed by the X-Linked Lymphoproliferative SyndromeThe Journal of Immunology, 2000
- X-Linked Lymphoproliferative DiseaseThe Journal of Experimental Medicine, 2000
- The gene defective in X-linked lymphoproliferative disease controls T cell dependent immune surveillance against Epstein–Barr virusCurrent Opinion in Immunology, 2000
- SLAM and its role in T cell activation and Th cell responsesImmunology & Cell Biology, 1997
- Soluble and Membrane-bound Forms of Signaling Lymphocytic Activation Molecule (SLAM) Induce Proliferation and Ig Synthesis by Activated Human B LymphocytesThe Journal of Experimental Medicine, 1997
- A novel receptor involved in T-cell activationNature, 1995
- Blast-1 possesses a glycosyl-phosphatidylinositol (GPI) membrane anchor, is related to LFA-3 and OX-45, and maps to chromosome 1q21-23.The Journal of Experimental Medicine, 1989
- X-LINKED RECESSIVE PROGRESSIVE COMBINED VARIABLE IMMUNODEFICIENCY (DUNCAN'S DISEASE)The Lancet, 1975